Winston et al. showed that plasma NDEs from patients with AD or MCI who later converted to AD contain elevated levels of P-T181-tau, P-S396-tau, and Aβ1-42, compared to cognitively normal controls and stable MCI patients. Here, MAPT is linked to Alzheimer disease.